POST Online Media Lite Edition


Perrigo announces leadership change in Rx pharmaceuticals segment

Staff Writer |
Dublin, Ireland - July 22, 2016, Dublin, Ireland - Perrigo Company plc, a healthcare supplier, announced the departure of Douglas Boothe, executive vice president and general manager, Rx Pharmaceuticals.

Article continues below

Mr. Boothe joined Perrigo in January 2013 as Executive Vice President and General Manager, Perrigo Pharmaceuticals.

Previously, Mr. Boothe served as Chief Executive Officer of Actavis Inc. from August 2008 to December 2013 and as Executive Vice President and Chief Operating Officer from 2006 to 2008.

Prior to that position, Mr. Boothe held various senior positions in strategic planning and business development for Alpharma Inc., Pharmacia Corporation and Xerox Corporation.

John Wesolowski, Senior Vice President of Rx Commercial Operations, will assume the role of Acting General Manager, Rx pharmaceuticals.


Irish Continental Group appoints Lesley Williams to board
Alkermes appoints two directors
Perrigo Company appoints Ray Silcock as chief financial officer
Glanbia appoints two independent non-executive directors
Cairn Homes appoints three independent non-executive directors

What to read next

Joseph C. Papa to be chairman and CEO of Valeant
Perrigo appoints EVP, GM
Perrigo names John Hendrickson CEO